Camilla Sylvest, Executive Vice President and Head of Business Strategy and Corporate Affairs at Novo Nordisk AS, has left the company

Zhitong
2025.04.03 06:57

On April 3rd, Novo Nordisk announced that Executive Vice President and Head of Business Strategy and Corporate Affairs Camilla Sylvest has decided to leave. The statement said that starting from April 3rd, Executive Vice President for Rare Diseases Ludovic Helfgott will be responsible for product and product portfolio strategy, including commercial strategy, medical affairs, and business development across all therapeutic areas. Senior Vice President of Product Supply Emerging Technologies Thilde Hummel Bøgebjerg has been promoted to Executive Vice President of Quality, IT, and Environmental Affairs. Executive Vice President of Human Resources and Organization Tania Sabroe will also take on global communications in addition to her current responsibilities

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.